Ganoderic Acid B

• CAT Number: R018926
• CAS Number: 81907-61-1
• Molecular Formula: C30H44O7
• Molecular Weight: 516.67
• Purity: ≥95%
• Synonyms: (3β,7β,25R)-3,7-Dihydroxy-11,15,23-trioxolanost-8-en-26-oic Acid
• Storage: Store at -20°C
• IUPAC Name: (2R,6R)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid
• InChI: InChI=1S/C30H44O7/c1-15(10-17(31)11-16(2)26(36)37)18-12-23(35)30(7)25-19(32)13-21-27(3,4)22(34)8-9-28(21,5)24(25)20(33)14-29(18,30)6/h15-16,18-19,21-22,32,34H,8-14H2,1-7H3,(H,36,37)/t15-,16-,18-,19+,21+,22+,28+,29-,30+/m1/s1
• InChIKey: LWPLEHFGBRFRKI-NBCWKOIPSA-N
• SMILES: CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(CC(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)C)C

Ganoderic acid B（Cat No.:R018926） is a triterpene compound derived from Ganoderma lucidum, a medicinal mushroom. It possesses various biological activities. Ganoderic acid B has been found to inhibit the activation of Epstein-Barr virus (EBV) antigen, making it a potential telomerase inhibitor. Furthermore, it exhibits moderate inhibitory effects against HIV-1 protease, suggesting its potential in the development of antiviral therapeutics. Research on ganoderic acid B continues to explore its mechanisms of action and potential applications in the treatment of viral infections and related diseases.